The Alcarelle science team is comprised of highly experienced clinical research scientists, and is led by Professor David Nutt, Edward Safra Chair of NeuroPsychopharmacology at Imperial College.
Prof. David Nutt, DM, FRCP, FRCPsych, FMedSci, DLaws – Chief Scientific Officer
Psychiatrist and neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety and sleep. Currently the Edmond J Safra chair in Neuropsychopharmacology at Imperial College, London. His book Drugs Without the Hot Air (UIT press) won the Transmission Prize for Communicating Science in 2014.
David Orren CEng MBA – Managing Director
Experienced managing director in the innovation and technology sector. Broad international experience in successfully bringing to market disruptive innovation. Chairman of Thames Valley Business Advisors Ltd.
Dr Jane Bailey, MSc, PhD – Clinical Process Lead
Translational Scientist in Mental Health. Fellow in Psychopharmacology at the University of Bristol with wide experience in psychophysiological effects of stress and anxiety and the effects of treatment. Work has included the development and delivery of early phase clinical trials in healthy participants and patients.
Dr Joubert Gama, MB.Ch.B, CertPvPe, FFPM,(CCT) – Medical Officer
Pharmaceutical physician and final signatory. Therapeutic areas include Anaesthesia, Bio-surgery, Cardiovascular (hypertension, CHD), CNS (Alzheimer's, Parkinson’s, Restless legs syndrome, Migraine, Peripheral Neuropathic Pain), Infant /Adult Nutrition, Psychiatry (Depression, Anxiety, Schizophrenia), Women’s Health. General surgery/trauma/General Practice and Drug Dependancy.
Dr Louise Paterson, BSc, PhD – Pharmacology Lead
Pharmacologist and Clinical Research experience in areas of sleep medicine, addiction biology, functional neuroimaging and in the management of human experimental medicine studies and clinical trials. Current research at Imperial College London, is focussed on understanding the brain mechanisms of addiction and relapse using experimental medicine and brain imaging techniques.
Dr Robin Tyacke, BSC PhD – BioChemistry Lead
Wide experience in neuropsychopharmacology and specifically in the translational pharmacological evaluation and development of novel small molecules for use in humans, from concept to initial first in human studies. Experienced in the design and project management of human experimental clinical trials.
Dr Sue Wilson, PhD – Physiology/Medical Lead
Hon Senior Research Fellow, Centre for Psychiatry, Division of Brain Sciences, Imperial College London. Research focus on the use of cognitive and physiological testing, including EEG and objective sleep measurement, in the study of drugs and their neurotransmitter actions in the human brain, in healthy volunteers and in patients with psychiatric, sleep and physical disorders.
Phil Edwards, BSc FCA - Chairman
Combining history as a Chartered Accountant followed with wide ranging UK amd European Managing Director roles in the technology sector, with wide experience of diverse product innovation and company development.